The objective of a phase II cancer clinical trial is to screen a treatment that can produce a similar or better response rate compared to the current treatment results. This screening is usually carried out in two stages as proposed by Simon. For ineffective treatment, the trial should terminate at
Adaptive Two-Stage Designs for Single-Arm Phase IIA Cancer Clinical Trials
โ Scribed by Yong Lin; Weichung J. Shih
- Book ID
- 110725185
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 160 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0006-341X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Cytotoxic chemotherapy produces modest benefits for patients with recurrent and metastatic squamous cell carcinoma of the head and neck (SCCHN). Prospective randomized clinical trials have failed to demonstrate unequivocal superiority of aggressive multidrug regimens over single agents. Despite this
We developed an interactive and menu-driven computer program to help investigators design and analyze phase II cancer clinical trials with a group sequential method, namely the sequential probability ratio test or the triangular test. Based on the values selected for the parameters of the trial, the